Lupin receives GMP certificate from PMDA, Japan for its Mandideep API facility (Unit II)

Lupin announced the receipt of GMP (Good Manufacturing Practice) Certificate from the Pharmaceutical and Medical Devices Agency (PMDA), Japan for its Mandideep API facility (Unit II). The GMP Certificate was issued following an inspection conducted by PMDA between 14 May 2019 and 17 May 2019.

The PMDA inspection closed with no critical or major observations. The GMP Certificate issued by PMDA for Mandideep facility (Unit II) is valid till September 2024

Powered by Capital Market - Live News